Tiny magnets offer breakthrough in gene therapy for cancer

The team are now looking at how effective magnetic targeting is at delivering a variety of different cancer-fighting genes, including ones which could stop the spread of tumours to other parts of the body.

Contact

Professor Claire Lewis, University of Sheffield
Tel: 0114 2712903, email:
Professor Jon Dobson, University of Keele
Tel: 01782 554 047, email:

BBSRC Media Office
Tracey Jewitt, Tel: 01793 414694, email:
Matt Goode, Tel: 01793 413299, email:
Nancy Mendoza, Tel: 01793 413355, email:

University of Sheffield Media Office
Lindsey Bird, Tel: 0114 222 5338, email:

University of Keele Media Office
Chris Stone, Tel: 01782 583375, email:

University of Nottingham Media Office
Lindsay Brooke, Tel: 0115 9515793, email:

Notes to Editors

This research is published online in Gene Therapy today and will be published in the journal Gene Therapy on 3 June 2008. The research was carried out jointly by Professor Claire Lewis and Dr Munitta Muthana, University of Sheffield, Professor Jon Dobson and Dr. Neil Farrow, Keele University and Professor Helen Byrne and Dr Giles Richardson, University of Nottingham.
The research was funded by the Biotechnology and Biological Sciences Research Council.

About BBSRC

The Biotechnology and Biological Sciences Research Council (BBSRC) is the UK funding agency for research in the life sciences. Sponsored by Government, BBSRC annually invests around £380 million in a wide range of research that makes a significant contribution to the quality of life for UK citizens and supports a number of important industrial stakeholders including the agriculture, food, chemical, healthcare and pharmaceutical sectors. http://www.bbsrc.ac.uk